EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pomegranate‐Derived Nanovesicles Exert Therapeutic Effects by Modulating Inflammatory Responses in a Murine Model of Chronic Dermatitis

Miquel Martínez-Navarrete, Christian Sánchez-López iD, Antonio José Guillot García iD, M Carmen Recio, Rosa M Giner, Antonio Marcilla iD, Ana Melero

Journal of Extracellular Vesicles · 2026-11 · 15 (11)

DOI: 10.1002/jev2.70403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 05.11.2026. Verfasst von Miquel Martínez-Navarrete und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Technology and Parasitology, Faculty of Pharmacy and Food Sciences, Universitat de València, Valencia, Spai…. Hauptthemen laut MEDLINE: Dermatitis, Pomegranate, Anti-Inflammatory Agents, Inflammation. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agencia Estatal de Investigación, Ministerio de Ciencia, Innovación y Universidades, Conselleria d'Educació, Cultura i Universitats, Generalitat Valenciana, Valencia, Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles are gaining attention in the pharmaceutical field due to their potential as therapeutic and delivery platforms. Among these, plant nanovesicles (PNVs) are particularly promising due to their reported biological activity. Pomegranate ( Punica granatum ) has been widely used in traditional medicine for its antioxidant and anti‐inflammatory properties. Recent studies have revealed that pomegranate juice contains PNVs with therapeutic potential. In this study, pomegranate‐derived nanovesicles ( Pg NVs) were isolated, characterized, and pharmacologically evaluated in dermatitis‐like in vivo murine models of delayed‐type hypersensitivity (DTH) and chronic dermatitis. Subcutaneous administration of Pg NVs modulated pro‐inflammatory cytokine expression, particularly by reducing IL‐4 and IL‐1β levels in the DTH model. Moreover, in the chronic dermatitis model, Pg NVs‐treated mice exhibited reduced histopathological skin damage, decreasing epidermal hyperplasia, collagen deposition, and immune cell infiltration. Additionally, Pg NVs enhanced the secretion of the anti‐inflammatory cytokine IL‐10, while decreasing the levels of pro‐inflammatory mediators like IL‐1β. Importantly, the long‐term effects of Pg NVs treatment were compared to those of topical corticosteroids (TCS), which constitute the current standard treatment for dermatitis. Unlike TCS, Pg NVs did not induce side effects. Overall, these findings support the therapeutic potential of Pg NVs as a promising, safe and sustainable alternative approach to treat chronic inflammatory skin diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatitisPomegranateAnti-Inflammatory AgentsInflammationAnimalsMiceDisease Models, AnimalChronic DiseaseInterleukin-1betaFemaleCytokinesSkinHypersensitivity, DelayedMice, Inbred BALB C

Stichwörter der Autor:innen

Pomegranateatopic dermatitischronic dermatitisinflammatory skin diseasesnanovesicles

Substanzen

Anti-Inflammatory AgentsInterleukin-1betaCytokines

Autor:innen und Institutionen

  • Department of Pharmacy and Pharmaceutical Technology and Parasitology, Faculty of Pharmacy and Food Sciences, Universitat de València, Valencia, Spain.
  • Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM), Valencia, Spain.
  • Joint Unit on Endocrinology, Nutrition and Clinical Dietetics, IIS La Fe-Universitat de València, Valencia, Spain.
  • Department of Pharmacology, Faculty of Pharmacy and Food Sciences, Universitat de València, Valencia, Spain.

ORCID-Profile: Christian Sánchez-López, Antonio José Guillot García, Antonio Marcilla

Förderung

  • Agencia Estatal de Investigación
  • Ministerio de Ciencia, Innovación y Universidades
  • Conselleria d'Educació, Cultura i Universitats, Generalitat Valenciana, Valencia, Spain
  • Generalitat Valenciana; Conselleria d'Innovació, Universitats, Ciència i Societat Digital

Zitieren

APA

Martínez-Navarrete, M., Sánchez-López, C., García, A. J. G., Recio, M. C., Giner, R. M., Marcilla, A., & Melero, A. (2026). Pomegranate‐Derived Nanovesicles Exert Therapeutic Effects by Modulating Inflammatory Responses in a Murine Model of Chronic Dermatitis. Journal of Extracellular Vesicles, 15(11). https://doi.org/10.1002/jev2.70403

Vancouver

Martínez-Navarrete M, Sánchez-López C, García AJG, Recio MC, Giner RM, Marcilla A, et al. Pomegranate‐Derived Nanovesicles Exert Therapeutic Effects by Modulating Inflammatory Responses in a Murine Model of Chronic Dermatitis. Journal of Extracellular Vesicles. 2026;15(11). doi:10.1002/jev2.70403

BibTeX
@article{MartnezNavarrete2026,
  author = {Martínez-Navarrete, Miquel and Sánchez-López, Christian and García, Antonio José Guillot and Recio, M Carmen and Giner, Rosa M and Marcilla, Antonio and Melero, Ana},
  title = {Pomegranate‐Derived Nanovesicles Exert Therapeutic Effects by Modulating Inflammatory Responses in a Murine Model of Chronic Dermatitis},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/jev2.70403}
}
Kostenlos starten →